Add Yahoo as a preferred source to see more of our stories on Google. Researchers at Moffitt Cancer Center have discovered a triple immunotherapy that may shrink tumors in treatment-resistant melanoma ...

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Bispecific antibodies first reached patients as cancer treatments, but a growing number of companies are working to expand these therapies to autoimmune diseases. Sanofi is adding a new contender, ...

To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...

A cheap, old transplant drug can delay full diabetes onset in young children.

Baylor College of Medicine and Site Tx, Inc. are collaborating to develop novel small-molecule drugs that allow for the fine-tuning of immune responses in multiple disease. Focusing on small molecule ...

(THE CONVERSATION) When the first cells appeared on Earth approximately 3.8 billion years ago, viruses were already here to greet them. Ever since, viruses have been devising ways to infect cells, and ...

Combining the direct cytotoxic effects of antibody-drug conjugates (ADCs) with the immune-enhancing properties of immunostimulators represents a new therapeutic strategy that could not only eradicate ...

Engineered immune cells spark cancer immunotherapy hope, following metabolic by-products secreted by cancer cells to ...

Rheumatoid arthritis is an autoimmune disorder that causes inflammation, swelling and pain in joints. It can have a range of impacts, and as of 2019, was thought to impact about 18 million people ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced its participation at the 23rd Annual Meeting of the Japanese Society of Medical Oncology ...